Novogen Company Profile

05:20 EST 21st November 2017 | BioPortfolio

Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disease) Osteoporosis Rheumatoid arthritis Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease) Neurological diseases (Parkinson's Disease, motor neurone disease) Autoimmune diseases (multiple sclerosis, diabetes, lupus etc). While there are drugs available to treat these diseases, they either are poorly effective or only slow the rate of progression of the disease or are associated with unwanted side-effects. Novogen is addressing this urgent area of medical need through the Novogen isoflavonoid technology platform - a platform that the Company believes offers the real prospect of not only treating, but also preventing, the onset of these common degenerative conditions. To meet the challenge of an ambitious target of product development, the Company is structured into four divisions.

Novogen Ltd is a public Australian biotechnology company whose shares trade on both the Australian Stock Exchange (symbol ‘NRT’) and NASDAQ (symbol ‘NVGN’).  The Company is based in Sydney, Australia and is focused on the development of novel anti-cancer drugs based on two proprietary drug technologies - the super-benzopyran chemical family and anti-tropomyosin drug technology


Suite 1.02
16-20 Edgeworth David Ave
New South Wales


Phone: (+61 2) 9476 0344
Fax: (+ 61 2) 9476 0388

News Articles [11 Associated News Articles listed on BioPortfolio]

Novogen to launch midstage study of brain cancer candidate

A midstage clinical trial of GDC-0084 for the treatment of glioblastoma is expected to be launched by Novogen in the fourth q -More- 

Novogen (NRT) - GDC-0084 Phase II on track to commence Q417

Edison Investment Research - Pharmaceutical & healthcare - Novogen: Novogen is on track to commence a Phase II trial of GDC-0084 in glioblastoma in Q4 CY17, in line with previous guidance. It plans to...

Novogen says Cantrixil trial progressing as planned

Novogen, an ASX-listed oncology drug development company, has announced that its phase I clinical trial of Cantrixil in ovarian cancer is progressing as planned.  The trial commenced in December 201...

Novogen Restructures, Board to Take Pay Cuts

Novogen Board Directors Take 50% Pay Cut to Conserve Cash

  Life Sciences Jobs   ...

Novogen Release: Progress Update On Cantrixil (TRXE-002-1) Development

  Life Sciences Jobs   ...

Novogen Release: GDC-0084 Progress Update: On Track For Phase II Commencement In 2017

  Life Sciences Jobs   ...

Novogen irons out Phase 2 plans for brain cancer candidate

Contract research organization Chiltern will help the company conduct a mid-stage study slated for the fourth quarter.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


Novogen's business is in the most pressing area facing medicine in the modern era - that of degenerative diseases and disorders. Cancer Heart disease (stroke, hypertension, coronary artery disea...

Marshall Edwards

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of...

More Information about "Novogen" on BioPortfolio

We have published hundreds of Novogen news stories on BioPortfolio along with dozens of Novogen Clinical Trials and PubMed Articles about Novogen for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novogen Companies in our database. You can also find out about relevant Novogen Drugs and Medications on this site too.

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Corporate Database Quicklinks

Searches Linking to this Company Record